Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02544503 · ClinicalTrials.gov registry record · NA
Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02544503 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 100 participants.
The verdict
NCT02544503, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to identify and establish how the area of the brain that controls motor function (motor cortex) of the non-affected hemisphere after stroke might serve as a new target for therapeutic interventions to improve motor performance after stroke.
Interventions
- DEVICE Single-pulse Transcranial Magnetic Stimulation (TMS)
- DEVICE Paired-pulse Transcranial Magnetic Stimulation (ppTMS)
- DEVICE Low-frequency Repetitive Transcranial Magnetic Stimulation (rTMS)
- DEVICE Sham Motor Cortex Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-11-05 |
| Est. Completion | 2021-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02544503
The ClinicalTrials.gov registry entry for NCT02544503 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Single-pulse Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT02544503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02544503 about?
NCT02544503 is a clinical study titled "Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients". The purpose of this study is to identify and establish how the area of the brain that controls motor function (motor cortex) of the non-affected hemisphere after stroke might serve as a new target for therapeutic interventions to improve motor performance after stroke.
What is the current status of trial NCT02544503?
This trial is currently terminated. It is a NA study. The enrollment target is 100 participants. The study started on 2015-11-05. Estimated completion is 2021-02-04.
What interventions are being tested in trial NCT02544503?
The interventions under investigation include: Single-pulse Transcranial Magnetic Stimulation (TMS) (DEVICE), Paired-pulse Transcranial Magnetic Stimulation (ppTMS) (DEVICE), Low-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE), Sham Motor Cortex Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02544503?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.